Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Caicun Zhou, Xingxiang Xu et al.|Journal of Thoracic Oncology|2021Cited by 311
High expression of GPNMB indicates an unfavorable prognosis in glioma: Combination of data from the GEO and CGGA databases and validation in tissue microarrayFeng Xiao, Shundong Cang|Oncology Letters|2020Cited by 45
LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentinHao Feng, Shundong Cang|Biomarker Research|2024Cited by 6